Project Optimus: The evolution of dose optimisation in oncology
Project Optimus seeks to transform how doses are selected and optimised in oncology drug development. As this initiative grows, the need for diverse data insights will affect clinical trial timelines and costs. Can advanced diagnostics help identify the right dose based on a patient’s molecular profile, pharmacodynamics, and tumour biology?
